Verdant PhytoMed — Company Overview

Registration: Republic of South Africa, Companies Act 71 of 2008

Verdant PhytoMed (Pty) Ltd Business PlanSection 2 › Company Overview

Section 2 · Business Plan

Company Overview

Registration: Republic of South Africa, Companies Act 71 of 2008

2.1 Company Details

Legal Name: Verdant PhytoMed (Pty) Ltd
Registration: Republic of South Africa, Companies
Act 71 of 2008
Industry: Medicinal Cannabis Cultivation, Processing
& Export
Registered Address: Stellenbosch, Western Cape,
South Africa
Date of Incorporation: To be incorporated upon
investment commitment
B-BBEE Status: Level 2 Contributor (Targeted)

2.2 Ownership Structure

The Company’s equity structure has been designed to balance founder operational control with institutional investor governance rights and broad-based black economic empowerment (B-BBEE) compliance. The Employee Trust mechanism ensures staff retention and alignment with long-term value creation.

Shareholder Role Equity (%) Vesting
Dr. Thabo Ndlovu Founder & CEO (Pharmacologist) 40% 4-yr cliff
Amara van der Westhuizen COO (Agribusiness Expert) 25% 4-yr cliff
Orion Capital Partners Ltd Institutional Investor 30% Immediate
Employee Trust (B-BBEE) Staff Incentives 5% 3-yr vest

2.3 Vision, Mission & Values

Vision: To be Africa’s leading pharmaceutical-grade
cannabis company and a globally recognised supplier of medicinal
cannabis products.
Mission: To cultivate, process, and export
world-class medicinal cannabis products under the highest international
compliance standards, creating sustainable value for shareholders,
employees, and the communities in which we operate.

Core Values

  • Compliance is non-negotiable and constitutes our primary competitive moatRegulatory Excellence:

  • Every product decision is grounded in pharmaceutical scienceScientific Rigour:

  • Job creation, community upliftment, and environmental stewardshipSustainable Impact:

  • Big 4-calibre governance, financial controls, and reporting standardsOperational Discipline:

2.4 Management Team

Dr. Thabo Ndlovu — Founder & Chief Executive Officer

Dr. Ndlovu holds a PhD in Pharmacology from the University of Cape Town and has over 15 years of experience in pharmaceutical product development and regulatory affairs. He previously served as Head of Product Development at a leading South African pharmaceutical manufacturer, where he managed a portfolio of over 40 registered medicines. His deep understanding of SAHPRA regulatory processes and international pharmaceutical quality standards positions him uniquely to navigate the complex medicinal cannabis licensing landscape.

Amara van der Westhuizen — Chief Operating Officer

Ms. van der Westhuizen is a seasoned agribusiness professional with 12 years of experience in large-scale commercial farming operations in the Western Cape. She holds an MBA from Stellenbosch University and a BSc in Agriculture from the University of Pretoria. Her expertise in greenhouse cultivation, supply chain optimisation, and agricultural technology deployment will be instrumental in achieving the Company’s production targets.

Advisory Board

  • Professor of Pharmaceutical Sciences, University of the Western Cape; regulatory strategy advisorProf. Johann Meyer:

  • Senior Cannabis Law Practitioner; SAHPRA licensing and compliance specialistAdv. Sipho Mkhize:

  • Former EU-GMP Auditor; international quality assurance advisorDr. Sarah Blackwood:

  • Managing Partner, Pan-African Agri-Fund; strategic finance and M&A advisorMr. David Okonkwo:

This document contains proprietary and confidential information. Distribution without written consent is prohibited.